We found 194 results for your search.
Joshua Lakin serves as the clinical lead for the Serious Illness Care Program at Brigham & Women’s Hospital, both in primary care and general inpatient medicine settings. His recent research focuses on the implementation of the program in primary care. He plays a key role in the Serious Illness Care Program at Ariadne Labs to… Continue reading Joshua Lakin, MD*
Susan Block is a Senior Consultant to the Serious Illness Care Program at Ariadne Labs, a joint center for health care innovation at Brigham & Women’s Hospital and Harvard T.H. Chan School of Public Health and Professor of Psychiatry and Medicine at Harvard Medical School. She founded the program in 2011, and served as its… Continue reading Susan Block, MD*
Rachelle Bernacki, MD, MS, is the Director of Quality Initiatives in the Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute. Dr. Bernacki played a key role in developing the Serious Illness Care Program at Ariadne Labs, which has developed a standardized approach for ensuring clinicians conduct discussions about end-of-life values and goals… Continue reading Rachelle Bernacki, MD, MS
The Frontline documentary, Being Mortal, co-written by Dr. Atul Gawande and inspired by his bestselling book, has been nominated for an Emmy Award in Outstanding Informational Programming, Long Form. Three years in the making with Gawande as the correspondent, the PBS documentary explores the themes introduced in his 2014 book Being Mortal, Medicine and What… Continue reading Frontline Documentary Being Mortal nominated for Emmy Award
Katrinka Quirk, MS, is a research assistant for the Serious Illness Care Program, working with the team documenting patient and family feedback addressing the effectiveness of the Serious Illness Conversation Guide at the Dana-Farber Cancer Institute.
Ernest Mandel, MD, SM, is a Faculty Investigator on the Serious Illness Care Program, and is working to expand the Serious Illness Communication Program to the end-stage kidney disease (dialysis) population.
Josh Lakin is a Palliative Care Physician, Dana-Farber Cancer Institute and Brigham & Women’s Hospital; Assistant Professor of Medicine, Harvard Medical School Josh serves as the clinical lead for the Serious Illness Care Program at Brigham & Women’s Hospital, both in primary care and general inpatient medicine settings. His recent research focuses on the implementation… Continue reading Joshua Lakin, MD
Caroline Grogan, MSc, is the Associate Director of Ariadne Labs Project Management. She has managed multiple programs for Ariadne over the past several years, including Primary Health Care and Safe Surgery projects and BetterBirth and Serious Illness Care Program teams, bringing a management lens to a wide range of innovation, research and implementation work. Before… Continue reading Caroline Grogan
Rachelle Bernacki, MD, MS, is the Lead Faculty, Community of Practice, Serious Illness Care Program at Ariadne Labs. In addition, Rachelle is Director of Quality Initiatives, Psychosocial Oncology and Palliative Care at the Dana-Farber Cancer Institute and is a faculty member at Harvard Medical School. Rachelle is board certified in Palliative Medicine, Geriatrics, and Internal… Continue reading Rachelle Bernacki
Andrew Dreyfus is a health care executive and expert in health care system change. He served from 2010 to 2022 as President and Chief Executive Officer for Blue Cross Blue Shield of Massachusetts (BCBSMA), a plan with over $9 billion in revenue and three million members. Under his leadership, BCBSMA was known as an innovator… Continue reading Andrew Dreyfus